ValuEngine upgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a buy rating in a research report released on Friday morning, ValuEngine reports.

EDAP has been the topic of a number of other reports. HC Wainwright set a $7.00 price objective on shares of Edap Tms and gave the company a buy rating in a research note on Friday, August 30th. Zacks Investment Research upgraded shares of Edap Tms from a sell rating to a hold rating in a research report on Tuesday, July 16th. Finally, TheStreet downgraded Edap Tms from a b- rating to a d+ rating in a research note on Monday, June 17th.

Edap Tms stock opened at $3.63 on Friday. The company has a market cap of $107.29 million, a PE ratio of 52.86 and a beta of 1.87. The company has a current ratio of 2.40, a quick ratio of 1.97 and a debt-to-equity ratio of 0.09. Edap Tms has a 1 year low of $1.35 and a 1 year high of $5.42. The company’s 50-day moving average is $3.17 and its two-hundred day moving average is $3.35.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. Edap Tms had a net margin of 4.57% and a return on equity of 23.31%. The company had revenue of $14.04 million during the quarter, compared to analysts’ expectations of $11.92 million. Research analysts forecast that Edap Tms will post 0.18 EPS for the current year.

Several hedge funds have recently made changes to their positions in the company. Hilton Capital Management LLC bought a new position in Edap Tms during the 1st quarter worth approximately $75,000. JPMorgan Chase & Co. bought a new stake in Edap Tms in the second quarter valued at approximately $282,000. Susquehanna International Group LLP increased its stake in Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after purchasing an additional 181,401 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Edap Tms in the second quarter valued at approximately $607,000. Finally, Morgan Stanley raised its holdings in Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 184,539 shares during the period. 13.24% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Featured Story: Percentage Decliners

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.